Skip to main content
. 2020 Mar 30;35(7):1300–1312. doi: 10.1002/jbmr.3999

Table 2.

Baseline of the Pooled Data, and Percent Change at 12 months in QCT Variables, by Group

Variable Total baseline (n = 66) Control %ΔV5 (n = 13) Low magnitude (n = 13) %ΔV5 High magnitude %ΔV5 (n = 17) Low rate %ΔV5 (n = 12) High rate %ΔV5 (n = 11)
Ultradistal
iBV (cm3) 3.84 ± 0.40 −1.17 ± 2.51 0.75 ± 2.14 −0.01 ± 2.23 −0.29 ± 1.29 0.35 ± 1.86
iBMC (g) 0.91 ± 0.15 −1.31 ± 2.68 0.46 ± 1.52 −0.33 ± 2.03 2.73 ± 2.07 3.42 ± 2.21
iBMD (g/cm3) 0.24 ± 0.03 −0.59 ± 2.08 −0.23 ± 0.96 −0.33 ± 1.19 3.03 ± 1.08 3.07 ± 1.46
ecBV (cm3) 1.99 ± 0.15 −0.41 ± 1.49 0.89 ± 1.39 0.34 ± 1.58 −0.01 ± 1.25 0.41 ± 1.46
ecBMC (g) 0.63 ± 0.18 −0.19 ± 4.87 0.12 ± 2.46 −0.10 ± 2.62 4.84 ± 3.64 4.45 ± 3.47
ecBMD (g/cm3) 0.31 ± 0.08 0.21 ± 4.52 −0.74 ± 2.79 −0.43 ± 2.59 4.85 ± 3.46 4.03 ± 3.30
Total
iBV (cm3) 12.96 ± 1.55 −0.06 ± 0.47 −0.25 ± 0.52 −0.13 ± 0.45 0.16 ± 0.64 0.38 ± 0.41
iBMC (g) 5.10 ± 0.60 −0.23 ± 1.20 −0.45 ± 0.80 −0.19 ± 0.78 1.97 ± 0.86 1.93 ± 0.75
iBMD (g/cm3) 0.39 ± 0.04 −0.17 ± 1.14 −0.19 ± 0.58 −0.06 ± 0.78 1.81 ± 0.63 1.55 ± 0.86
ecBV (cm3) 8.24 ± 0.72 0.17 ± 0.71 −0.07 ± 0.57 0.18 ± 0.44 0.45 ± 0.62 0.35 ± 0.64
ecBMC (g) 4.09 ± 0.55 0.15 ± 1.78 −0.26 ± 1.11 0.00 ± 1.01 2.06 ± 1.40 1.72 ± 1.37
ecBMD (g/cm3) 0.50 ± 0.05 −0.02 ± 1.28 −0.20 ± 0.76 −0.18 ± 0.98 1.60 ± 0.84 1.36 ± 0.83
Ultradistal strength
CSA (cm2) 4.15 ± 0.42 −0.67 ± 1.67 0.65 ± 1.45 0.00 ± 1.48 −0.26 ± 1.23 0.35 ± 1.75
CSI (g2/cm4) 0.24 ± 0.07 −1.81 ± 4.40 0.18 ± 1.96 −0.65 ± 2.85 5.90 ± 3.05 6.62 ± 3.26
BSI (cm3) 0.12 ± 0.03 −0.59 ± 4.31 0.32 ± 1.90 −0.29 ± 2.30 4.74 ± 2.44 4.81 ± 2.70

Data are shown as mean ± SD. Bold indicates significant regression coefficient representing contrast with control group for raw change. Baseline is for participants with follow‐up data available. %ΔV5 = percent change at visit 5.